Insulet Corp
NASDAQ:PODD
Insulet Corp
NASDAQ:PODD
Price:
174.43 USD
0.58%
Market Closed
Updated:
May 5, 2024
Insulet Corp
Revenue
|
Insulet Corp
Revenue Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Insulet Corp
NASDAQ:PODD
|
Revenue
$1.7B
|
CAGR 3-Years
23%
|
CAGR 5-Years
25%
|
CAGR 10-Years
21%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$19.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$14.7B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$21B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$40.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$7.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
Insulet Corp
Revenue Breakdown
Breakdown by Geography
Insulet Corp
Insulet Corp
|
Total Revenue:
1.7B
USD
|
|
United States:
1.3B
USD
|
|
International:
410.1m
USD
|
Breakdown by Segments
Insulet Corp
Insulet Corp
|
Total Revenue:
1.7B
USD
|
|
Total Omnipod Products:
1.7B
USD
|
|
Drug Delivery:
36m
USD
|
See Also
What is Insulet Corp's Revenue?
Revenue
1.7B
USD
1.7B
USD
Based on the financial report for Dec 31, 2023, Insulet Corp's Revenue amounts to 1.7B USD.
What is Insulet Corp's Revenue growth rate?
Revenue CAGR 10Y
21%
21%
Over the last year, the Revenue growth was 30%. The average annual Revenue growth rates for Insulet Corp have been 23% over the past three years , 25% over the past five years , and 21% over the past ten years .
You don't have any saved screeners yet
